ReviewJournal of clinical medicine2025

Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Targeting Sarcomeric Hypercontractility with Demonstrated Long-Term Safety and Efficacy-A Narrative Review.

Ghaith K Mansour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.